As EU officials work on a third round of revisions on the proposed settlement with Google, reports say chances for an agreement continue to dwindle.
European Commissioner Joaquin Almunia has faced significant criticism by Google rivals, consumer advocates and even fellow Commissioners for his plans to approve of a settlement offered by Google to end years of an antitrust dispute over how Google displays its own and rivals’ search results.
After rejections, Google has offered to feature links from rival services in prominent spots in its search results. Almunia has signaled that he is steadfast on approving the offer and closing the case before he exits the position later this year.
Even with the case settled, Almunia assured, Google would continue to face significant antitrust scrutiny and investigations by the European Commission.
But reports suggest that the settlement could be collapsing as Almunia has still not officiated the deal.
The latest challenge to the settlement comes from a group of publishers across the EU. Challengers are now calling on Almunia to either force harsher terms on the settlement, or leave the matter to be resolved by his successor.
Almunia is set to leave his post in November. Reports say his replacement will likely take a more critical stance against Google.
Full content: NYTimes
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas